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The very incomprehensibility of the suicidal act has been occupying the minds of
researchers and health professionals for a long time. Several theories of suicide have
been proposed since the beginning of the past century, and a myriad of neurobiological
studies have been conducted over the past two decades in order to elucidate its
pathophysiology. Both neurobiology and psychological theories tend to work in parallel
lines that need behavioral and empirical data respectively, to confirm their hypotheses.
In this review, we are proposing a “Life Span Model of Suicide” with an attempt to
integrate the “Stress-Diathesis Model” and the “Interpersonal Model of Suicide” into a
neurobiological narrative and support it by providing a thorough compilation of related
genetic, epigenetic, and gene expression findings. This proposed model comprises three
layers, forming the capability of suicide: genetic factors as the predisposing Diathesis on
one side and Stress, characterized by epigenetic marks on the other side, and in between
gene expression and gene function which are thought to be influenced by Diathesis
and Stress components. The empirical evidence of this model is yet to be confirmed
and further research, specifically epigenetic studies in particular, are needed to support
the presence of a life-long, evolving capability of suicide and identify its neurobiological
correlates.
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INTRODUCTION
Twice as many suicides as homicides are reported in the US every year (Heron, 2016) reflecting not
only its enormous public health impact but also the lack of public awareness. About one million
people die of suicide worldwide with the highest rates seen in white middle-aged men. Suicide
is the tenth leading cause of death in the US and each year ∼42,773 Americans die by suicide.
The annual age-adjusted suicide rate is ∼12.93/100,000 and costs the US $44 billion annually
(Prevention AFfS, 2014). Even though the cause of suicidal behavior is thought to be multifactorial
(Hawton and van Heeringen, 2009), one of the most common risk factors is a psychiatric disorder
(Arsenault-Lapierre et al., 2004) amongst which mood disorders, major depressive disorder, and
bipolar disorder rank the highest (Harris and Barraclough, 1997).
The very incomprehensibility of the suicidal act has been occupying the mind of researchers and
health professionals for a long time. Several theories have been proposed over the past decades,
describing underlying factors, acute triggers and populations at risk. One of the most influential
models proposed by Mann’s group (Mann et al., 1999), was by applying the diathesis-stress model
on suicidal behavior. It describes individuals having a certain vulnerability (“diathesis”) to suicidal
behavior, which in combination with psychosocial crises or psychiatric disorders (“stress”), will
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result in actual suicidal behavior (Mann et al., 1999; van
Heeringen, 2012; van Heeringen and Mann, 2014). Another
acclaimed theory is the Interpersonal Theory of Suicide, a three-
factor model by Joiner and colleagues. The Interpersonal Theory
of suicide is a psychological model which proposes suicidal desire
and capability of suicide as the principal factors (Joiner, 2005).
Suicidal desire explained by high levels of burdensomeness and
thwarted belongingness are cognitive variables which are difficult
to describe in a neurobiological frame, whereas the capability of
suicide might be explained by the sum of genetic, epigenetic and
environmental factors which will be discussed in this review.
The neurobiology of suicide is a vast field, ranging from
candidate gene studies in the very beginning (Abbar et al., 1995)
to miRNA expression recently (Smalheiser et al., 2012). Genetic
associations between suicide and polymorphisms of the HPA-
axis (Fudalej et al., 2015; Yin et al., 2016), serotonin system
(Anguelova et al., 2003; Bach and Arango, 2012; de Medeiros
Alves et al., 2015; Höfer et al., 2016), noradrenergic system
(Chandley and Ordway, 2012) and polyamines (Fiori et al., 2010)
have been established. For a thorough review of neurobiological
findings from the neuroimaging point of view, it is useful to
consult van Heeringen’s and Mann’s recent publication (van
Heeringen and Mann, 2014).
Psychological theories and neurobiological findings tend to
work in parallel: both need behavioral and empirical data to
confirm their claims. In this review, we are proposing a Life
Span Model of Suicide with an attempt to integrate Joiner’s
Interpersonal Model of Suicide and Mann’s Stress-Diathesis
Model and support it by providing a thorough compilation of
related neurobiological findings.
SUICIDE AND MODELS OF SUICIDE
Suicide, self-harm, and attempted suicide are highly complex
behaviors which are thought to be multifactorial and the
contributing factors can be divided into “proximal and distal
stressors” or state- and trait-dependent factors (Hawton and van
Heeringen, 2009). A dozen psychological models of suicide have
been described, tested, and empirically supported (Barzilay and
Apter, 2014). Amongst most of these models, stress seems to be
a key cause for primary psychopathology, and the act of suicide
is often envisioned as a reaction to extreme unbearable stress.
Unfortunately, stress models of suicidal behavior cannot explain
the reasons why extreme stress does not lead to suicide in all stress
exposed individuals. For instance, not all individuals exposed to
childhood trauma will develop psychiatric problems indicating
the need to examine the role of diathesis in selected individuals
(van Heeringen, 2012).
The Stress-Diathesis-Model
These above described observations paved the way to a better
explanatory model of suicide proposed by Mann et al. that
involves a predisposing diathesis as a “distal risk factor” which
when combined with “proximal risk factors” act as precipitants
and increases the risk of suicide (Mann et al., 1999). Distal risk
factors include developmental, personality, family, and genetic
factors such as childhood adversities, family history of suicide,
and impulsive-aggressive personality traits. Proximal risk factors
include life events, stress, and psychiatric disorders including
substance abuse. Interestingly, suicidal patients differ from non-
suicidal patients in distal stressors and additionally, proximal risk
factors might serve as triggers for suicidal behavior (Roy et al.,
2009).
Mann et al. (1999) proposed a clinical model based on
findings from a sample of 347 consecutive patients admitted
for mood disorders, psychoses, and other diagnoses. Lifetime
suicide attempts, aggressive traits and impulsivity, objective
and subjective severity of psychopathology, developmental and
family history, and past substance abuse including alcoholism
were evaluated. Suicide attempters demonstrated higher scores
on subjective depression, more lifetime episodes of major
depression/psychoses, higher scores on suicidal ideation and
fewer reasons for living when compared to non-attempters. Also,
suicide attempters showed higher rates of lifetime aggression and
impulsivity, family history of suicide, head injury, and child abuse
when compared to non-attempters.
By factor analysis two state factors (psychosis and depression)
and one trait factor (aggression/impulsivity) were generated.
Using logistic regression, the authors demonstrated that
aggression/impulsivity was strongly associated with lifetime
suicide attempts whereas psychosis and depression were not
significant predictors of lifetime suicide attempt (Mann et al.,
1999).
Mann et al. (1999) proposed a hypothetical, predictive stress-
diathesis model in which the risk for suicidal actions is not only
due to a proximal stressor but also due to a distal stressor—
the diathesis. To reach the threshold of suicidal behavior, both
components are required. Mann’s model conceptualizes diathesis
as a dynamic condition of continuous character, underlining that
it can vary during the lifespan and that it is not dichotomous.
Melhem et al. (2007) demonstrated that diathesis for suicide is
partly heritable and has familial transmissions across offspring.
Per Mann, elements of the diathesis including aggressive-
impulsive traits, hopelessness, more severe suicidal ideation and
cognitive inflexibility could enhance the individual’s increased
risk of completed suicide.
Since it has been proposed that the diathesis component of
Mann’s model follows (at least partially) the laws of heritability,
we are suggesting that the diathesis represents genetic factors in
a neurobiological model of the capability of suicide.
Early life adversities are one of the strongest predictors of
suicidal behavior in adulthood (Santa Mina and Gallop, 1998).
The high prevalence of adverse life events in suicidal individuals
have been confirmed by several sociodemographic studies (Liu
and Miller, 2014). A crucial question in these studies as well as in
the theoretical models is the definition of “stressful life events”
or “stress.” An encyclopedia describes these traumatic events
as “rape, combat exposure, sexual, or physical abuse, partner
violence or negative life events such as death of family member,
divorce, loss of child custody, break up with significant other,
bullying, verbal abuse, chronic medical/psychiatric problems
such as physical illness, substance abuse, physical pain, feelings of
hopelessness, and so on” (Figley, 2012). Stress per Mann’s model
could refer to psychosocial crises as well as development of a
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psychiatric disorder (Mann, 2003). In other publications “stress”
mostly refers to early life adversities (Currier and Mann, 2008;
Mann and Currier, 2010). Since this model attempts to combine
two theories and since Joiner’s referencing of stress covers a much
broader field, the definition of the factor “stress” will be expanded
to “Stress and Trauma” including life events such as combat
exposure, sexual, or physical abuse over the life span. The stress
component corresponds to the epigenome, life-events like the
ones above mentioned conveying long-lasting marks on genes,
affecting the risk of suicidal behavior over the life span (Labonté
and Turecki, 2012; Turecki et al., 2012).
The Interpersonal Theory of Suicide
The heart of “The Interpersonal Theory of Suicide” is the idea
that the capability to commit suicide is something that has to
be acquired throughout the lifespan—being juxtaposed to the
natural human survival instinct, which merely presents itself
as the individual’s fear of death. Joiner claims that even in
suicidal individuals, who have already acquired a certain level
of capability, it really is a conflict between these two contrasting
factors. This sort of capability can be acquired by experiencing
repetitive trauma and violence, which can take a wide range of
forms, from being a combat fighter (Selby et al., 2010a; Silva et al.,
2016) or experiencing proxy-violence and death (as physicians
do on a regular basis; Fink-Miller, 2015a,b) or the experience
of having attempted suicide or self-harming behavior in eating
disorders (Holm-Denoma et al., 2008; Selby et al., 2010b) to
being responsible for animal euthanasia (Platt et al., 2010,
2012). Also personality traits such as impulsivity are thought to
contribute to the individual’s capability. The two major features
of increased level of capability are reduced fear of death and
increased threshold of pain tolerance, which are thought to
interact with suicidal desire (ideation) and together lead up to
suicidal death (Van Orden et al., 2010). Joiner dissects suicidal
desire into two cognitive factors: thwarted belongingness and
perceived burdensomeness. Thwarted or failed belongingness are
synonyms for social alienation and loneliness, the experience
of being outside and not part of one’s family and peer group.
The theory argues that this feeling of isolation will contribute
vastly to one’s suicidal desire. Perceived burdensomeness is the
individual’s perceived conviction of being a burden to their peer
system and family (Joiner, 2005; Van Orden et al., 2012).
With regard to the proposed model, the capability of
suicide can be understood in terms of a spectrum rather
than in terms of a dichotomous variable. However, in the
actual clinical setting, differentiating suicide ideators and
attempters from death by completed suicide is one of the most
crucial tasks. Besides, there is a growing body of evidence
that the transition between suicide attempters and death by
completed suicide is not so seamless after all, arguing that
they represent distinct entities, and that they carry first and
foremost distinguishable features (Giner et al., 2013; Klonsky
et al., 2016).
We understand Joiner’s capability of suicide as a profoundly
biological concept, comprising factors that have been
scientifically assigned to genetics, epigenetics and layer of
gene function and gene expression. Factors like impulsivity
or individual’s aggression threshold have been associated with
genetic polymorphisms (Oquendo and Mann, 2000; Oquendo
et al., 2006); life time experiences like childhood adversities,
trauma (Yehuda et al., 2016), and combat exposure (Yehuda
et al., 2013; Kaminsky et al., 2015; Sadeh et al., 2016) have
been associated with epigenetic changes. Genetic influence on
the individual’s pain threshold has been conflicting (Eide and
Hole, 1993), but an involvement of the serotonin system has
been suggested in multiple publications (Lindstedt et al., 2012;
Horjales-Araujo et al., 2013; Schaldemose et al., 2014). Exposure
to suicide has been associated with a higher suicide risk for the
exposed individuals (Nanayakkara et al., 2013; Cerel et al., 2016),
but this factor has not been established from a neurobiological
perspective (Griffiths and Hunter, 2014).
THE LIFE SPAN MODEL OF SUICIDE AND
ITS NEUROBIOLOGICAL FOUNDATION
In our proposed merged model (Figure 1), Mann’s diathesis
reflects the genome of a suicidal individual. Genetic
polymorphisms of the serotonergic system (Bach and Arango,
2012; de Medeiros Alves et al., 2015; Höfer et al., 2016),
hypothalamic-pituitary-adrenal axis (Fudalej et al., 2015; Yin
et al., 2016), noradrenergic system (Chandley and Ordway,
2012), and polyamines (Fiori et al., 2010) predispose the
individual to suicidal behavior. These predispositions will also
interact with the risk of certain psychiatric disorders. Juxtaposed
with the diathesis of the capability of suicide, there is the
stress component, which corresponds to the epigenome of the
individual. Alterations in the epigenetic landscape reflect the sum
of noxious stimuli, traumatic events and experiences of death
and pain that increase the capability of suicide throughout the
lifespan. In between the genetic layer on the side of the diathesis
and the epigenetic layer on the side of the stress component,
we find the gene expression and function, which is thought to
be influenced by both. For example, FKBP5 is a well-known
suspect both in suicide research as well as in stress-activation
research. Functional genetic polymorphisms of FKBP5 are
known to change the gene and protein expression levels, which
might increase the individual’s vulnerability to stress and might
increase the likelihood of stress leaving long-lasting epigenetic
marks in the FKBP5 gene. It has been suggested that both the
genetic polymorphism and the long-lasting epigenetic mark are
present in the phenotypes of psychiatric disorders and suicide
(Provencal and Binder, 2015).
Below we summarize and discuss the neurobiological findings
relevant to the proposed model. The proposed model is trying to
meet the needs for a general suicide model with neurobiological
foundation, by acknowledging genetic dispositions, and also
including epigenetic and gene expression findings. The focus
is on post-mortem brain studies, since suicide attempters with
unknown intent to die are generally not included in these kinds
of studies. Providing a neurobiological foundation to the merged
models is an attempt of translation—to build bridges between
studies of empirical psychology and the latest neurobiological
findings.
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FIGURE 1 | The life span model of suicide. The capability of suicide is represented by an arrow directed toward the completion of suicide, as are two other arrows
representing thwarted belongingness and perceived burdensomeness. The capability of suicide is influenced by genetic, gene expression and epigenetic factors,
represented as layers. The proximity of the Epigenome to Stress and Trauma and of the Genome to the Diathesis are suggestive of their close association.
Genetics of Suicide
Suicide is a complex, multifactorial behavior phenotype and
a consequence of interactions of genetics and environment.
Family, twin, and adoption studies have supported the genetic
risk contribution to the psychopathology of suicide. Statistically,
it was estimated that the heritability for suicide approximately
reached 30–55% for suicidal behavior and ideation (Voracek
and Loibl, 2007). Here, we are illustrating the genetics of the
capability of suicide with candidate gene studies and genome
wide association studies, which contribute to the diathesis
component of the Life Span Model of Suicide. In Mann’s
model, the diathesis is dynamic, whereas our proposed model
understands the diathesis as a rather stable trait corresponding
to steady polymorphisms in the genome, not only modifying
the susceptibility to traumatic events and stress, but also the
vulnerability toward psychiatric disorders or psychosocial crises.
Candidate Gene Association Studies
A summary of candidate gene studies are provided in Table 1.
Candidate genes for suicide are primarily found in the
serotonergic system, dopaminergic system, and brain-derived
neurotrophic factor (BDNF). Studies suggest that low CSF levels
of 5-hydroxyindoleacetic acid (5-HIAA), the main metabolite
of serotonin (5-HT), were associated with increased aggressive
behavior, impulsiveness and a higher risk of suicide attempts
(Asberg et al., 1976; Linnoila and Virkkunen, 1992; Perroud
et al., 2010). The alteration of serotonergic function has been
demonstrated to correlate with the etiology and pathogenesis
of suicidal behavior. The tryptophan hydroxylase (TPH) gene,
a rate-limiting enzyme in the biosynthesis of 5-HT, is involved
in the dysfunction of the 5-HT system (Cooper and Melcer,
1961). Two different genes code for TPH: TPH1 and TPH2.
Both are major candidate genes for psychiatric and behavioral
disorders, in particular for mood disorders and suicidal behavior.
Turecki et al. (2001) genotyped the A218C loci of the TPH1
gene in a sample of 101 suicide victims and 129 controls from
the Canadian population. Although, the single loci analysis
showed no difference between the two groups, haplotype analysis
was significantly associated with suicide behavior (Turecki
et al., 2001). Within another Canadian postmortem sample,
no significant difference between suicide victims and controls
regarding the TPH gene 218A/C polymorphism were found (Du
et al., 2000). Furthermore, three studies with Croatian samples
focused on the same polymorphism (Jernej et al., 2004; Stefulj
et al., 2005, 2006). Interestingly, the results demonstrated that
the TPH gene has a significant effect on suicidality (Jernej
et al., 2004; Stefulj et al., 2006). A case-control study with 572
suicide victims and 1049 healthy controls in Denmark attempted
to confirm the association of TPH1 and TPH2 with suicide.
In the basic association test, the loci frequency of SNPs in
the TPH1 and TPH2 showed no significant difference between
the sample that died of suicide and the sample that died of
other reasons. However, further analyses showed that TPH1
polymorphism rs1800532 might have a protective effect for
specific populations including younger males and rs1800532
might be a predictive risk factor in elderly male subjects
(Buttenschø et al., 2013). This finding raises the important
question whether rs1800532 has a differential role in young
vs. adult population. More mechanistic studies need to be
performed. Also, these findings should be further explored in a
larger population as well as in other cohorts of subjects. Roy et al.
(2001) found the TPH A779C allele frequency to be higher in the
livingMZ twins of suicide victims than in controls. No significant
differences in polymorphisms of A218C or A779C were found
in a Japanese sample (Ono et al., 2000; Ohtani et al., 2004).
Recently, a meta-analysis reviewed more than 30 publications
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TABLE 1 | Genome-wide association studies in suicidal behavior and ideation.
Clinical finding Sample size
(cases)
Total No. of
SNPs
SNP (Gene) References
Suicidal ideation 180 (90) 109,365 rs11628713 (PAPLN), rs10903034 (IL28RA) Laje et al., 2009
Suicidal ideation 706 (244) 539,199 rs11143230 (GDA), rs4732812 (ELP3) rs358592 (KCNIP4) Perroud et al., 2012
Suicidal ideation 397 (32) 371,335 rs1037448 (TMEM138) rs10997044 (CTNNA3) rs1109089 (RHEB) Menke et al., 2012
Suicide attempters 3,117 (1,295) ∼1.9 × 106 rs2576377 (ABI3BP) rs4918918 (SORBS1) rs10854398 (B3GALT5)
rs1360550 (PRKCE)
Perlis et al., 2010
Suicide attempters 2,023 (251 ) 532,774 rs4751955 (GFRA1), rs203136 (KIAA1244) Schosser et al., 2011
Suicide attempters 5,815 (2,496) ∼730,000 rs300774 (2p25, ACP1, SH3YL1, FAM150B) Willour et al., 2012
Suicide completers 99 (68) 37,344 58 SNPs (19 genes) Galfalvy et al., 2013
Suicide attempters 3,270 (426) 532,774 rs17173608 (RARRES2) rs17387100 (PROM1) rs3781878 (NCAM1) Mullins et al., 2014
Suicide attempters and
suicide completers
1,800 (577) 794,207 rs11852984 (intergenic) rs6480463 (ADAMTS14) rs4575 (PSME2/RNF31)
rs336284 (TBX20) rs3019286 (STK3)
Galfalvy et al., 2015
SNP, single-nucleotide polymorphism.
with genetic association studies of TPH1 and TPH2. The meta-
analysis of TPH1 included 5,683 cases and 11,652 controls.
The results demonstrated that the polymorphisms rs1800532
(A218C) and rs1799913 (A779C) were associated with suicidal
behavior. Three SNPs (rs4570625/G-703 T, rs11178997/A-473 T,
and rs1386494/G19918A) in TPH2 gene were investigated in a
sample of 4,196 cases and 5,990 controls. No significant results
were detected suggesting that TPH2 might not play a significant
role in suicidal behavior (González-Castro et al., 2014). Stefulj
et al. (2011) conducted an association study in 291 subjects who
died of suicide and 280 subjects who died of other causes and
found no significant differences in the distribution of the TPH2
polymorphism G-703 T between the two groups (Stefulj et al.,
2011).
The gene coding for 5HTT (SLC6A4, 37.8 kb at 17q11.1–
q12) is another widely studied candidate gene for suicide.
An insertion/deletion polymorphism in the promoter region
contains two or three alleles called short (s) and long (IA and
IG). Bondy et al. (2000a) were the first to find a highly significant
increased frequency of suicide victims being carriers of one
or two short alleles. These positive associated results (Bondy
et al., 2000a) were replicated by two other studies (Courtet
et al., 2004; Lopez de Lara et al., 2006). Anguelova et al. (2003)
performed a meta-analysis, pooling 12 studies with a focus on
the 5-HTT promoter polymorphism. A total of 1,168 cases
(suicide victims and attempters) and 1,371 controls (including
Caucasian US and Chinese population) were analyzed, and a
significant association of the s allele with suicidal behavior
was demonstrated (Anguelova et al., 2003). A recent meta-
analysis including 2,536 cases and 3,984 controls also supported
the association of the 5-HTTLPR in suicidal behavior (Schild
et al., 2013). Clayden et al. (2012) conducted a sub-analysis for
suicide completers including 6 studies with a total of 860 suicide
victims and 1,234 healthy controls. No significant association
between the suicide risk and the short polymorphism of HTTLPR
could be established. However, the rs1800532 polymorphism was
significantly associated with a higher risk for suicide attempts
(Clayden et al., 2012). Compared with the sample size of suicide
attempters, the number of suicide victims was relatively smaller,
which might have caused a loss of significance in a number
of studies. Taken together, these studies provide evidence that
5-HTTLPR may play a crucial role in suicidal behavior.
BDNF, a member of the neurotrophin family of growth
factors, is also a promising candidate gene for suicide behavior
(Dwivedi, 2012). Among the SNPs within the region of BDNF,
the Val66Met (rs6265) has received the most attention in genetic
studies of suicide. This polymorphism is a missense mutation at
position 66 resulting in a valine to methionine substitution. A
significant association between BDNF Val66Met polymorphism
and suicidal behavior could be shown in several studies (Iga
et al., 2007; Zai et al., 2012). González-Castro et al. (2015)
found an association between genotype Val-Val and suicide
attempts in bipolar patients. Pregelj et al. (2011) investigated
the BDNF Val66Met polymorphism in whole blood collected
during autopsy of 359 suicide victims and 201 controls. A
significant difference in the frequency of the Met genotype was
found between female suicide victims and female control group.
Additionally, the Met/Met genotypes of BDNF Val66Met could
predict the risk of dying by suicide in female subjects with
violent and childhood trauma (Pregelj et al., 2011). Recently,
Ratta-Apha et al. (2013) explored the association between BDNF
polymorphisms with suicide. The Met-allele was shown to be
associated with attempted suicide, but not with death by suicide
(Ratta-Apha et al., 2013).
Genome-Wide Association Studies of Suicidal
Behavior
Genome-wide association study (GWAS) provides a powerful
tool for analyzing more than one million single nucleotide
polymorphisms (SNPs) at a time. This approach has been
applied in identifying novel genes in suicide research. To date,
nine original GWAS studies have been performed to test for
association with suicidal behavior (Laje et al., 2009; Perlis et al.,
2010; Schosser et al., 2011; Menke et al., 2012; Perroud et al.,
2012;Willour et al., 2012; Galfalvy et al., 2013, 2015;Mullins et al.,
2014) which are all listed in Table 2. Generally, few genome-wide
significant and reproducible findings have been demonstrated
for suicidal behavior. In this review we focused on GWAS
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TABLE 2 | Candidate gene associations studies of suicide completers.
Gene SNP Population No. case/No. controls P-value OR (95% CI) References
TPH1 A218C Canada 35/84 0.49 1.22 (0.69–2.13) Du et al., 2000
A218C Canada 101/129 0.48 1.00 (0.69–1.45) Turecki et al., 2001
A218C Croatia 185/358 0.0156 1.46 (0.22–0.95) Jernej et al., 2004
A218C Croatia 160/284 0.0728 0.76 (0.57–1.01) Stefulj et al., 2005
A218C Croatia 247/320 0.0019 0.80 (0.63–1.02) Stefulj et al., 2006
A218C Denmark 490/1,027 >0.05 0.93 (0.80–1.09) Buttenschø et al., 2013
A218C Japan 132/132 >0.05 1.04 (0.74–1.47) Ono et al., 2000
A218C Japan 134/325 0.2 0.94 (0.69–1.28) Ohtani et al., 2004
TPH1 A779C Sweden 24/158 0.094 0.51 (0.27–0.97) Roy et al., 2001
A779C Japan 134/325 0.251 1.10 (0.81–1.48) Ohtani et al., 2004
TPH2 G-703T Croatia 291/280 0.7159 0.94 (0.74–1.25) Stefulj et al., 2011
G-703T Japan 234/260 0.249 0.85 (0.66–1.09) Mouri et al., 2009a
A-473T Slovenia 383/222 0.968 1.0194 (0.48–2.18) Zupanc et al., 2011
A-473T Japan 234/260 0.95 0.99 (0.39–2.56) Mouri et al., 2009b
5-HTTLPR S/L allele Caucasian 58/110 0.0019 2.08 (1.32–3.29) Bondy et al., 2000b
S/L allele Caucasian 40/112 0.01 2.83 (1.29–6.22) Courtet et al., 2004
S/L allele French Canadian 106/152 0.002 1.02 (0.71–1.47) Lopez de Lara et al., 2006
BDNF Val66Met Slovenia 359/201 0.021 1.09 (0.81–1.48) Pregelj et al., 2011
Val66Met Slovenia 262/250 0.853 1.06 (0.79–1.43) Zarrilli et al., 2009
Val66Met Japan 300/374 0.753 0.97 (0.78–1.21) Ratta-Apha et al., 2013
studies in suicide victims. Galfalvy et al. (2013) reported the first
GWAS study in suicide victims. Caucasian subjects, including
68 suicides and 31 non-suicide deaths, were genotyped using
low-coverage sequencing. 58 potentially associated SNPs with
significance levels <0.001 were identified, instead of adjusting
them with the Benjamini–Hochberg procedure. Among those
top associated SNPs, 22 SNPs were located within 19 genes
whose functions were already known. Gene expression analysis
found that nine of those 19 genes were altered in the prefrontal
cortex of suicide victims, including CD44, FOXN3, DSC2, and
CD300LB (Galfalvy et al., 2013). A very recent GWAS study
was conducted with a mixed sample of suicide attempters,
suicide victims (n = 577) and healthy controls (n = 1233).
Due to smaller effect sizes, no variants reached genome-wide
significance. Notably, several SNPs within ADAMTS14 and
PSME2 (both linked to inflammatory response), STK3 (neuronal
cell death), and TBX20 (brainstem motor neuron development)
were ranked as candidate genes for further analyses (Galfalvy
et al., 2015). Willour et al. (2012) conducted a GWAS study and
compared the SNPs between 1201 bipolar subjects with and 1497
bipolar subjects without history of suicide attempts. 2507 SNPs
were identified with an evidence for association at P < 0.001.
These associated SNPs were subsequently tested for association
in a large and independent bipolar sample, but no significant
associations could be established after correcting for multiple
testing (Willour et al., 2012).
Overall only a few of these GWAS studies presented significant
data after correction formultiple testing, however they do suggest
interesting candidate genes that may be worthwhile to follow
up in future studies. We could speculate that individual genetic
susceptibility factors for suicide are likely to have only minor
effects and very large pooled analyses of cases and controls will
be necessary to identify them.
Epigenetics of Suicide
Epigenetic regulation is heritable and known to influence gene
function by different biochemical modifications other than
altering the DNA sequence (Eccleston et al., 2007). Despite
their close association with disease pathophysiology and active
participation in regulating developmental pathways (Portela
and Esteller, 2010; Cantone and Fisher, 2013), epigenetic
modification is a relatively new concept in suicide neurobiology
(El-Sayed et al., 2012).
DNA methylation based epigenetic modifications confer
silencing in gene expression involving a covalent attachment of
a methyl group to cytosine residues (Moore et al., 2013). This
was found to be true for a wide spectrum of genes, for pathways
including the γ-aminobutyric acid (GABA) neurotransmission,
HPA axis related stress response system and the polyamine
system of the suicide brain (Turecki, 2014a). Part of this DNA
methylation process also involves the neurotropic system (Duclot
and Kabbaj, 2015). A summary of these methylation-based
studies is provided in Table 3.
Evidence from the GABAergic system has shown deficiency
in GABAA α1 receptor subunit expression in the frontal cortex
of suicide victims (Klempan et al., 2009; Poulter et al., 2010)
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TABLE 3 | Methylation status in postmortem suicide brains.
System Findings Brain region Gene References
GABAergic system Promoter hypermethylation Frontal cortex GABAA α1 receptor Poulter et al., 2008
Polyaminergic system Promoter hypermethylation Frontal cortex SMOX Fiori and Turecki, 2010
Promoter hypermethylation Frontal cortex SAT1 Fiori and Turecki, 2011
Promoter hypomethylation BA44 (frontal cortex) AMD1 Galfalvy et al., 2013
Promoter hypomethylation BA44 (frontal cortex) ARG2 Galfalvy et al., 2013
Neurotrophic system Promoter hypermethylation Wernicke’s area BDNF Keller et al., 2010
3′UTR hypermethylation Frontal cortex TRKB.T1 Maussion et al., 2014
Promoter hypermethylation Frontal cortex TRKB Ernst et al., 2009
HPA axis Promoter hypermethylation Hippocampus NR3C1 transcript variant
1B, IC and 1H
Labonte et al., 2012
with a corresponding change in the site-specific methylation at
promoter gene for the GABAA receptor (Poulter et al., 2008).
A similar downregulation of expression was observed for a
set of genes (SMOX, SMS, and SAT1) from the polyamine
system in various Brodmann areas (including BA 4, 8/9, and
11) of suicide completers (Fiori et al., 2011; Limon et al., 2016).
Proximal promoter analysis of both SMOX and SMS genes
did not find significant overall changes in methylation, except
for one site (+73) on the SMOX promoter and concomitant
decreased SMOX expression level in the same area (Fiori
and Turecki, 2010). An overall change in methylation pattern
was identified in the SAT1 promoter region of 10 suicide
completers, which included three highly polymorphic sites (Fiori
and Turecki, 2011). In agreement with the hypothesis, a strong
negative correlation was noted between the overall promoter
methylation and SAT1 gene transcription. As mentioned above,
the presence of three highly polymorphic sites (rs6526342,
rs928931, and rs1960264) on SAT1 promoter added an additional
layer of haplotype specific gene regulation driven by DNA
methylation. Amongst the three sites, rs6526342 showed
methylation enrichment in the suicide group albeit no significant
correlation with SAT1 expression. The frequent occurrence of
a hypermethylated “C” allele in suicide subjects was considered
to be associated with downregulated SAT1 expression (Fiori and
Turecki, 2011). A possible explanation might be an inaccessible
DNA structure affecting the binding of potential transcription
inducers (NF-E2, YY1, and AP-1) with the SAT1 gene promoter
(Fiori and Turecki, 2011).
Studies of additional polyamine related genes such as
ornithine decarboxylase antizymes 1 and 2 (OAZ1 and OAZ2),
AMD1 and arginase 2 (ARG2) show expression upregulation
(Gross et al., 2013; Limon et al., 2016). Interestingly, the
hyperfunctional status for all four genes was found to be
associated with promoter hypomethylation. Contrary to the
overall methylation status, site specific CpG hypomethylation
on AMD1 (CpG9, CpG16) and ARG2 (CpG5-7 and CpG42-
44) promoters were found to be highly significant in suicide
victims. This hypomethylation status was further supported by
the significant negative correlation between two specific CpG
sites (CpG9 and 16) and AMD1 gene expression whereas CpG5-
7 was found to be negatively correlated with gain of function
of ARG2 gene. This was not found to be true for OAZ1 and
OAZ2 genes, although site-specific as well as overall differences
inmethylation between controls and suicide victims were noticed
for all four genes investigated (Gross et al., 2013).
An interesting observation on lower BDNF expression was
noted in suicide victims (Dwivedi et al., 2003a; Banerjee et al.,
2013) with concomitant change in BDNF exon IV based
methylation status (Keller et al., 2010). Analysis of four CpG sites
(+10, +16, +25, and+28) of BDNF exon IV in the Wernicke’s
area identified a significant mean methylation difference between
suicide and non-suicide subjects (Keller et al., 2010). Following
the same pattern, analysis ofmethylation difference for individual
CpG sites on exon IV indicated a significant correlation between
suicidal behavior and the hypermethylation status of two CpG
site (+10 and +25). Moreover, lower expression of BDNF gene
was noticed in those suicide subjects who had earlier shown
exon IV promoter hypermethylation (Keller et al., 2010). These
observations suggest that epigenetic influence on neurotrophic
deficiency results in improper modulation of neural plasticity
(Dwivedi, 2009; Duclot and Kabbaj, 2015), a common finding in
suicide brains (Dwivedi et al., 2005).
DNA based methylation in dysregulating gene function
was further evidenced from studies in astrocytes of suicide
subjects (Maussion et al., 2014; Nagy et al., 2015). These
studies identified three potential hypermethylated sites on
3′untranslated region (UTR) of TRKB gene in suicide victims,
which showed 3′ UTR-mediated epigenetic regulation on
compromised TRKB.T1 isoform expression (Maussion et al.,
2014). Structural characterization of TRKB.T1 3′UTR indicated
the presence of four CpG sites (CpG6–CpG9) within a
span of 150 base pairs. Methylation analysis of these four
CpG sites showed significant methylation enrichment in the
suicide group compared to the control group; additional
statistical analysis established a significant correlation between
methylation and expression levels. Contrary to this, earlier
reports on decreased TRKB.T1 expression has shown a
different mechanism of DNA methylation mediated regulation
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in BA 8/9 of suicide subjects which involved two specific
hypermethylated CpG sites on TRKB promoter (Ernst et al.,
2009).
Addressing the epigenetic influence on suicide neurobiology
remains incomplete without discussing the functional
involvement of the HPA axis. In a postmortem brain
expression and methylation study, hippocampal NR3C1
expression was found to be significantly decreased in 12
suicide victims. Interestingly, DNA methylation analysis
(promoter NR3C1 exon 1F) was found to be closely associated
with childhood adversity (McGowan et al., 2009). A recent
report has identified similar site-specific DNA methylation
changes related to three non-coding glucocorticoid (GR)
transcript variants (1B, IC, and 1H) in hippocampal regions
of suicide victims with a history of childhood abuse
(Labonte et al., 2012). This indicates an integral role of
coordinated DNA methylation response to alter the GR
functionality, resulting in HPA axis dysregulation in suicide
subjects.
Taken together, the studies discussed herein suggest the
functional implication of DNA methylation based epigenetic
modifications in dysregulating multiple cellular pathways in
brain areas primarily involved in neurocognitive and vegetative
functions. These cellular abnormalities may give rise to an overall
dysfunctional state in information processing andmay eventually
contribute to the individual’s capability of suicide (Turecki,
2014b).
Gene Expression and Function
Postmortem findings of gene expression and gene function
studies point to a hyperactivation of the HPA-system, a
downregulated serotonin system and decreased levels of BDNF
compared to non-psychiatric control subjects or psychiatric
patients who died of reasons other than suicide. In this review,
we are focusing primarily on postmortem brain studies, since
the reliability and the validity of peripheral biomarkers has
been questioned before (Blasco-Fontecilla et al., 2013; Niculescu
et al., 2015; The Lancet, 2016) and suicide attempters might also
confound the variable we are attempting to define: the capability
of suicide (Table 4).
Several early studies investigated the association between
the HPA-axis and suicide by autoradiographic and ligand
binding techniques, describing an overexpression of CRH and
a subsequent downregulation of the corresponding receptors
(Nemeroff et al., 1988; Merali et al., 2006). Studies focusing
on molecular gene expression in post-mortem samples of
suicide victims show a similar picture: downregulated CRHR1
receptor (not CRHR2) (Merali et al., 2004), increased pro-
opiomelanocortin (POMC) mRNA but no difference in GR
(glucocorticoid receptor) mRNA (López et al., 1992); no
difference between the expression levels of CRHR1 and CRHR2,
but a difference in the CRHR1/CRHR2-ratio (Hiroi et al.,
2001) compared to control subjects. More recent studies found
significantly decreased GR-α protein and mRNA expression in
teenage suicide victims’ amygdala and PFC (Pandey et al., 2013),
TABLE 4 | Gene expression findings in postmortem suicide brains.
System Findings Brain region Gene References
HPA Axis Downregulation PFC CRHR1 Merali et al., 2004
Upregulation PFC, ACC CRH Zhao et al., 2015
Downregulation PFC, amygdala GR-alpha Pandey et al., 2013; Pérez-Ortiz et al., 2013
Downregulation amygdala FKBP5 Pérez-Ortiz et al., 2013
Upregulation Pituitary POMC López et al., 1992
Serotonergic Upregulation Cortex, hippocampus 5HT2A Stanley and Mann, 1983; Turecki et al., 1999;
Pandey et al., 2002; Escribá et al., 2004
Upregulation of edited isoform of pre-mRNA PFC 5HT2C Niswender et al., 2001; Lyddon et al., 2013; Di
Narzo et al., 2014
Noradrenergic Upregulation Locus coeruleus TH Pandey and Dwivedi, 2007
Upregulation PFC α2 adrenergic receptor Pandey and Dwivedi, 2007
Inconclusive data PFC β2 adrenergic receptor Pandey and Dwivedi, 2007
Upregulation Cortex COMT Du et al., 2014
Neurotrophins Downregulation PFC, hippocampus BDNF Dwivedi et al., 2003a; Banerjee et al., 2013; Du
et al., 2014
Downregulation Hippocampus NGF Banerjee et al., 2013
Downregulation PFC, hippocampus TRKB Dwivedi et al., 2003a; Ernst et al., 2009;
Banerjee et al., 2013
Downregulation hippocampus TRKA Banerjee et al., 2013
Downregulation PFC, hippocampus PI-3 Dwivedi et al., 2008
Downregulation PFC, hippocampus CREB Dwivedi et al., 2003b; Pandey et al., 2007
PFC, prefrontal cortex; ACC, anterior cingulate cortex.
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and significantly reduced protein and mRNA expression levels of
GR and FKBP5 in the amygdala of suicide victims (Pérez-Ortiz
et al., 2013).
A very recent study examined postmortem transcription levels
in depressed suicide victims, depressed subjects who died from
non-suicidal causes, and subjects without any psychiatric history.
Interestingly, depressed suicide victims carried a distinctive
transcription profile, different from prior findings: CRH mRNA
was significantly increased in the suicide group, CRHR1 and
GR failed to show significance but were upregulated compared
to the other two groups and CRHR2 showed an insignificant
downregulation (Zhao et al., 2015).
The abundant serotonin receptor 5HT2A has been the focus
of neurobiological suicide studies for a long time. The majority
of publications reported an increased level of 5HT2A receptors
in the cortical area of suicide victims (Stanley and Mann, 1983;
Turecki et al., 1999; Escribá et al., 2004); mRNA expression
seems to be increased in the hippocampus area as well (Pandey
et al., 2002). A recent study found no significant changes of
monoamine-related genes (5HTA1, 5HT2A, MAOA, MAOB)
in a group of MDD-suicide subjects compared to non-suicidal
MDD subjects and controls without any psychiatric history
(Zhao et al., 2015). Of all 14 serotonin receptors, 5HT2C is one
of the less examined ones: Pandey et al. compared its mRNA and
protein expression in the PFC, hippocampus, and choroid plexus
between suicide victims and normal control subjects. They found
no significant differences in mRNA expression levels, but higher
levels of protein in the PFC of suicide victims (Pandey et al.,
2006). Recent publications suggest that a highly edited isoform
of the pre-mRNA of serotonin receptor 2C is overrepresented
in the brains of suicide victims and is significantly correlated to
gene expression levels of associated genes (Niswender et al., 2001;
Lyddon et al., 2013; Di Narzo et al., 2014).
A few studies investigating the noradrenergic system in
postmortem brain samples of suicide victims demonstrated
increased norepinephrine enzyme tyrosine hydroxylase (TH) and
increased α2- and β2-adrenergic receptors (Pandey and Dwivedi,
2007). As for catechol-O-methyltransferase (COMT), there was
only one gene expression study that reported significantly
increased COMT mRNA in cortex areas of depressed suicide
victims (Du et al., 2014).
In line with functional polymorphisms found in
postmortem brain samples of suicide victims, BDNF also
shows corresponding changes in gene expression and gene
function. Generally speaking, most of the studies were able to
find suicide-specific effects, which did not correlate with any
underlying condition or psychiatric disorder (Dwivedi, 2010).
A significant decrease in both BDNF gene expression and
corresponding protein expression has been reported in PFC and
hippocampus (Dwivedi et al., 2003a). Decreased gene expression
in the hippocampus and PFC but not in the entorhinal cortex
have been presented by Karege et al. (2005). The expression
of other neurotrophins such as NGF, NT-3, NT-4/5 has been
described as decreased as well (Dwivedi et al., 2005; Karege
et al., 2005). A recent study comparing depressed subjects to
suicide subjects and controls: BDNF and its receptors showed
a merely insignificant upregulation in the suicide group (Zhao
et al., 2015). Reduced neurotrophins (BDNF and NGF) as
well as reduced receptor (TRKB, TRKA) mRNA and protein
expression were found in the hippocampus of a sample of suicide
victims, compared with a sample of controls who died of other
causes (Banerjee et al., 2013). Decreased receptor expression of
TRKB in suicide victims has also been reported in several other
studies in hippocampus (Dwivedi et al., 2003a) and prefrontal
cortex (Dwivedi et al., 2003a; Ernst et al., 2009), incongruent
results have been reported for the Wernicke area (Keller et al.,
2011; Zarrilli et al., 2014). In line with the above mentioned
findings, phosphoinositide 3 (PI 3)-kinase, a key enzyme in the
neurotrophin pathway, was found to be decreased in PFC and
hippocampus of suicide victims (both mRNA and protein levels;
Dwivedi et al., 2008).
Cyclic-AMP response element binding (CREB) is an
important transcription factor that interacts with promoters
of genes involved in neuronal signaling (Sheng et al., 1990).
Its association with BDNF in particular (Finkbeiner, 2000)
makes CREB an interesting candidate for suicide studies.
Earlier studies found decreased immunoreactivities of both
CREB and phosphorylated CREB (Yamada et al., 2003),
decreased expression of CREB in postmortem brains of
drug-free MDD-patients (Yuan et al., 2010) and decreased
CREB protein expression in neutrophils of drug-free MDD
patients (Ren et al., 2011). Irrespective of the diagnosis, CREB
mRNA and protein expression were found to be significantly
decreased in the PFC and hippocampus of suicide victims,
compared to subjects without any psychiatric history (Dwivedi
et al., 2003b). In a sample of teenage suicide victims, these
findings were replicated in the PFC only (Pandey et al.,
2007).
Taken together, these findings indicate that changes in the
serotonin and the neurotrophin system as well as changes in the
HPA axis and CREB are contributing to the capability of suicide
on the level of gene expression.
CONCLUSIONS
When addressing suicide in the form of a model—as inclusive
as it can be—many factors unavoidably will be left out. Suicide
is a heterogeneous disorder and every suicidal act is unique in
its causes, forms and intentions. Causes (usually a psychiatric
disorder) and intentions might influence the method used
(violent vs. non-violent) and a method could influence the
outcome. All these differences make it difficult to address
suicide in the form of a model. Nevertheless, suicide models
are indispensable for an on-going scientific dialogue as well
as for the purpose of education. This review is an attempt to
construct a combined model of Mann’s Stress-Diathesis and
Joiner’s Interpersonal Theory, describing suicide as a total of
cognitive and neurobiological features. The focus of the Life
Span Model is on established neurobiological findings that
support the presence of a capability of suicide, represented
both by predisposing factors (“diathesis”) and contributing
factors (“stress and trauma”). Predisposing factors, increasing
the vulnerability of an individual might be found in the
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genetic code. These genetic variations might further increase
the individual’s vulnerability to post-transcriptional and post-
translational changes resulting from traumatic experiences and
stress throughout the lifespan. Hence, although our model
places genetics of suicide close to Mann’s “diathesis,” and
epigenetic changes close to “stress and trauma,” the likelihood
of in-between interactions cannot be denied. This brings us
to the point that the graphic depiction of this model is a
simplification of our current knowledge about the neurobiology
of suicide, albeit true with psychological models too. We
claim that there is a need for translational theories that have
the capability of reaching practicing clinicians and scientists,
and contribute to mental health education in general. With
psychiatric research in particular, there is a necessity for
established models to which greater audiences can relate. Further
research, particularly epigenetic studies, is needed to support the
presence of a life-long, evolving capability of suicide and identify
neurobiological correlates of susceptibility as well as protective
factors.
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